PLENARY KEYNOTE SESSION GAINING REGULATORY APPROVAL FOR MOLECULAR DIAGNOSTIC TESTS
Alberto Gutierrez, Ph.D., Deputy Director of OIVD, Office of in Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
Elliot Cowan, Ph.D., Chief, Product Review Branch, Division of Emerging and Transfusion Transmitted Diseases, FDA/CBER/OBRR
PRE-CONFERENCE SYMPOSIA (SC1) CIRCULATING TUMOR CELLS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS (SC2) REALITY CHECK ON COMPANION DIAGNOSTICS |
||
Cambridge Healthtech Institute 中文官方網站營運 : Cambridge Healthtech Institute 代理商 日商環球訊息有限公司